Targeting TDP-43 in Sporadic Amyotrophic Lateral Sclerosis

By
Bob
-
0
71
The authors examine key biological mechanisms underlying TDP-43 pathology, emerging therapeutic strategies, and evolving approaches to clinical trial design and biomarker development.
[Journal of Neurology]
Abstract